Brownstone Research is a boutique investment research firm that consistently delivers insights and profitable investment recommendations to its subscribers.
For too long, the best investment research has not been available to individual investors. It has been typically reserved for investment banks, hedge funds, private equity, and high-net-worth clients.
The mission of Brownstone Research is to make that kind of proprietary research available to any investors looking to gain an edge in the markets. The goal is simple… to deliver unique and profitable investment research found nowhere else.
Brownstone Research publishes one of the most widely read technology e-letters in the world, The Bleeding Edge, which delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.
Brownstone’s flagship investment newsletter, The Near Future Report, is focused on large-capitalization technology companies that are still in growth mode and deliver outsized returns. Its model portfolio consistently outperforms the markets year after year.
Additionally, Brownstone Research publishes highly specialized, alpha-driven investment research in Exponential Tech Investor and Early Stage Trader. Exponential Tech Investor focuses on small- and micro-capitalization technology companies on the bleeding edge, whereas Early Stage Trader focuses primarily on early stage, pre-revenue biotechnology companies developing novel approaches to curing human disease.
Founder and Chief Investment Analyst Jeff Brown is a high-technology executive with nearly 30 years of experience.
And as an active angel investor, Jeff has seen firsthand the wealth-creating potential of disruptive technology.
Today, Jeff Brown uses his technology, finance, and investing expertise to help everyday investors pinpoint companies on the verge of exponential growth.